Beta Drugs Ltd.

Financial

	Beta Drugs	Syncom Formulations	Jagsonpal Pharma
Operational Metrics
Financials
5 yr Average ROE	21.73 %	8.81 %	12.82 %
5yr average Equity Multiplier	1.75	1.5	1.29
5yr Average Asset Turnover Ratio	1.04	0.79	1.12
5yr Avg Net Profit Margin	11.97 %	7.78 %	8.95 %
Price to Book	0.0	4.95	7.52
P/E	41.17	34.25	29.67
5yr Avg Cash Conversion Cycle	15.7 Days	84.02 Days	-0.27 Days
Inventory Days	43.83 Days	27.61 Days	47.66 Days
Days Receivable	87.61 Days	123.89 Days	25.88 Days
Days Payable	113.94 Days	93.18 Days	68.7 Days
5yr Average Interest Coverage Ratio	13.71	39.83	56.07
5yr Avg ROCE	27.85 %	12.74 %	17.0 %
5yr Avg Operating Profit Margin	21.58 %	9.47 %	10.5 %
5 yr average Debt to Equity	0.23	0.2	0.02
5yr CAGR Net Profit	31.07 %	19.56 %	23.34 %
5yr Average Return on Assets	12.53 %	5.89 %	9.97 %
Shareholdings
Promoter Holding	66.73 %	50.57 %	67.65 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.02 %	0.0	-1.06 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Beta Drugs	Syncom Formulations	Jagsonpal Pharma
Product Wise Break-Up	Product Wise Break-Up Oncology 100.0 Renting of Property 0 Trading of Commodities 0 Pharmaceutical Drugs & Formulations 0 Pharmaceuticals 0	Product Wise Break-Up Rental Income 0.69 Pharmaceuticals 0 Commodity 1.36 Pharmaceutical 97.31 Oncology 0 Others 0.64	Product Wise Break-Up Renting of Property 0 Pharmaceuticals 100.0 Trading of Commodities 0 Pharmaceutical Drugs & Formulations 0 Oncology 0
Location Wise Break-Up	Location Wise Break-Up India 83.33 International 0 Others 16.67	Location Wise Break-Up International 78.11 India 0 Others 21.89	Location Wise Break-Up International 0 India 0 Others 100